These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 23470966)
21. Effective targeting of triple-negative breast cancer cells by PF-4942847, a novel oral inhibitor of Hsp 90. Mehta PP; Whalen P; Baxi SM; Kung PP; Yamazaki S; Yin MJ Clin Cancer Res; 2011 Aug; 17(16):5432-42. PubMed ID: 21715568 [TBL] [Abstract][Full Text] [Related]
22. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823 [TBL] [Abstract][Full Text] [Related]
23. Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer. Qamri Z; Preet A; Nasser MW; Bass CE; Leone G; Barsky SH; Ganju RK Mol Cancer Ther; 2009 Nov; 8(11):3117-29. PubMed ID: 19887554 [TBL] [Abstract][Full Text] [Related]
24. Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment. Dong D; Ko B; Baumeister P; Swenson S; Costa F; Markland F; Stiles C; Patterson JB; Bates SE; Lee AS Cancer Res; 2005 Jul; 65(13):5785-91. PubMed ID: 15994954 [TBL] [Abstract][Full Text] [Related]
25. Characterization of Peptides Targeting Metastatic Tumor Cells as Probes for Cancer Detection and Vehicles for Therapy Delivery. Subramanian S; Daquinag AC; AghaAmiri S; Ghosh SC; Azhdarinia A; Kolonin MG Cancer Res; 2021 Nov; 81(22):5756-5764. PubMed ID: 34607842 [TBL] [Abstract][Full Text] [Related]
26. Structure-based optimization of GRP78-binding peptides that enhances efficacy in cancer imaging and therapy. Wang SH; Lee AC; Chen IJ; Chang NC; Wu HC; Yu HM; Chang YJ; Lee TW; Yu JC; Yu AL; Yu J Biomaterials; 2016 Jul; 94():31-44. PubMed ID: 27088408 [TBL] [Abstract][Full Text] [Related]
27. ATAD3A stabilizes GRP78 to suppress ER stress for acquired chemoresistance in colorectal cancer. Huang KC; Chiang SF; Yang PC; Ke TW; Chen TW; Lin CY; Chang HY; Chen WT; Chao KC J Cell Physiol; 2021 Sep; 236(9):6481-6495. PubMed ID: 33580514 [TBL] [Abstract][Full Text] [Related]
28. A computational peptide model induces cancer cells' apoptosis by docking Kringle 5 to GRP78. Khater I; Nassar A BMC Mol Cell Biol; 2023 Aug; 24(1):25. PubMed ID: 37553635 [TBL] [Abstract][Full Text] [Related]
29. Synergistic promotion of breast cancer cells death by targeting molecular chaperone GRP78 and heat shock protein 70. Li M; Wang J; Jing J; Hua H; Luo T; Xu L; Wang R; Liu D; Jiang Y J Cell Mol Med; 2009; 13(11-12):4540-50. PubMed ID: 19017364 [TBL] [Abstract][Full Text] [Related]
30. Neoisoliquiritigenin Inhibits Tumor Progression by Targeting GRP78-β- catenin Signaling in Breast Cancer. Tang H; Peng F; Huang X; Xie X; Chen B; Shen J; Gao F; You J; Xie X; Chen J Curr Cancer Drug Targets; 2018; 18(4):390-399. PubMed ID: 28914191 [TBL] [Abstract][Full Text] [Related]
31. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Lou Y; McDonald PC; Oloumi A; Chia S; Ostlund C; Ahmadi A; Kyle A; Auf dem Keller U; Leung S; Huntsman D; Clarke B; Sutherland BW; Waterhouse D; Bally M; Roskelley C; Overall CM; Minchinton A; Pacchiano F; Carta F; Scozzafava A; Touisni N; Winum JY; Supuran CT; Dedhar S Cancer Res; 2011 May; 71(9):3364-76. PubMed ID: 21415165 [TBL] [Abstract][Full Text] [Related]
32. Tunicamycin-induced ER stress in breast cancer cells neither expresses GRP78 on the surface nor secretes it into the media. Serrano-Negrón JE; Zhang Z; Rivera-Ruiz AP; Banerjee A; Romero-Nutz EC; Sánchez-Torres N; Baksi K; Banerjee DK Glycobiology; 2018 Feb; 28(2):61-68. PubMed ID: 29206917 [TBL] [Abstract][Full Text] [Related]
33. Human neural stem cell tropism to metastatic breast cancer. Zhao D; Najbauer J; Annala AJ; Garcia E; Metz MZ; Gutova M; Polewski MD; Gilchrist M; Glackin CA; Kim SU; Aboody KS Stem Cells; 2012 Feb; 30(2):314-25. PubMed ID: 22084033 [TBL] [Abstract][Full Text] [Related]
34. Targeting lysophosphatidic acid receptor type 1 with Debio 0719 inhibits spontaneous metastasis dissemination of breast cancer cells independently of cell proliferation and angiogenesis. David M; Ribeiro J; Descotes F; Serre CM; Barbier M; Murone M; Clézardin P; Peyruchaud O Int J Oncol; 2012 Apr; 40(4):1133-41. PubMed ID: 22200658 [TBL] [Abstract][Full Text] [Related]
35. Chaperone-targeting cytotoxin and endoplasmic reticulum stress-inducing drug synergize to kill cancer cells. Backer JM; Krivoshein AV; Hamby CV; Pizzonia J; Gilbert KS; Ray YS; Brand H; Paton AW; Paton JC; Backer MV Neoplasia; 2009 Nov; 11(11):1165-73. PubMed ID: 19881952 [TBL] [Abstract][Full Text] [Related]
36. GRP78 enabled micelle-based glioma targeted drug delivery. Ran D; Mao J; Shen Q; Xie C; Zhan C; Wang R; Lu W J Control Release; 2017 Jun; 255():120-131. PubMed ID: 28344016 [TBL] [Abstract][Full Text] [Related]
37. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition. Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560 [TBL] [Abstract][Full Text] [Related]
38. Glucose regulated protein 78 (GRP78) inhibits apoptosis and attentinutes chemosensitivity of gemcitabine in breast cancer cell via AKT/mitochondrial apoptotic pathway. Xie J; Tao ZH; Zhao J; Li T; Wu ZH; Zhang JF; Zhang J; Hu XC Biochem Biophys Res Commun; 2016 Jun; 474(3):612-619. PubMed ID: 27012209 [TBL] [Abstract][Full Text] [Related]
39. The HGF inhibitory peptide HGP-1 displays promising in vitro and in vivo efficacy for targeted cancer therapy. Chen L; Li C; Zhu Y Oncotarget; 2015 Oct; 6(30):30088-101. PubMed ID: 26254225 [TBL] [Abstract][Full Text] [Related]
40. The phosphorylation-specific association of STMN1 with GRP78 promotes breast cancer metastasis. Kuang XY; Jiang HS; Li K; Zheng YZ; Liu YR; Qiao F; Li S; Hu X; Shao ZM Cancer Lett; 2016 Jul; 377(1):87-96. PubMed ID: 27130664 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]